Sitemap

December 26, 2019 Articles

Filter by Available Specialty
  1. Air pollution exposure may increase risk for depression, suicide
  2. Antidepressants reduce hyperglycemic crisis in diabetes with depressive disorder
  3. Anti-TNF alpha not linked with recurrent, new primary cancers in IBD
  4. BARDA awards Paratek up to $285 million to develop anthrax treatment
  5. BLOG: Can't get away from ocular surface health
  6. CGM scanned only intermittently yields ‘stable’ quality of life, reduces hypoglycemia vs. fingerstick tests
  7. Computer-automated decision support improves early screening rates for ASD
  8. Erythroferrone may function as negative regulator of bone remodeling in beta-thalassemia
  9. FDA approves generic travoprost
  10. FDA grants orphan drug designation to OBI-999 for pancreatic cancer
  11. HIV test-and-treat policies in NYC nearly halve time to treatment
  12. In PCI population, cancer confers mortality, bleeding risks
  13. Intradialytic symptoms common, linked to longer recovery time and shortened treatments
  14. Marijuana e-cigarette use significantly increases among students
  15. Mind-body therapies linked to improved pain, lower opioid dose
  16. New gene therapy appears safe, feasible for sickle cell disease
  17. NT-proBNP may predict death, myocardial injury after noncardiac surgery
  18. Order of THA, TKA does not impact length of stay in patients with arthritis
  19. Polyfunctional strength index identifies responders to combination immunotherapy in acute myeloid leukemia
  20. Pregnancy presents additional challenges in IBD
  21. PXL065 proves safe, well-tolerated ahead of phase 2 trial for NASH
  22. Read 2019’s most popular cornea/external disease articles
  23. REP2139 demonstrates functional cure in both HBV, HDV
  24. Sustained weight loss protects against breast cancer, FDA supports another indication for Keytruda — top stories in hematology/oncology
  25. Top dietary supplements news 2019: vitamin D, fish oil and more
  26. Trump signs spending bill that includes $5 million for KidneyX
  27. Ustekinumab beneficial through 1 year in SLE
  28. VIDEO: Avoiding ectasia following astigmatic keratotomy
  29. VIDEO: Surgeons should advocate more for patients, public
  30. Year in review: New treatment options, updates in ILD, IPF
  31. Ziv-aflibercept correlated with BCVA, CMT improvements